Viskase Holdings, Inc. (VISK): Net Income
-$3.41M
Year ended 2025-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.41M | n/m | 2026-03-02, From 2025-01-01 |
| 2024-12-31 | $778.0K | -43.3% | 2026-03-02, From 2024-01-01 |
| 2023-12-31 | $1.37M | n/m | 2025-02-21, From 2023-01-01 |
| 2022-12-31 | -$186.0K | n/m | 2024-03-20, From 2022-01-01 |
| 2021-12-31 | -$469.0K | n/m | 2023-02-16, From 2021-01-01 |
| 2020-12-31 | -$1.31M | n/m | 2022-02-25, From 2020-01-01 |
| 2019-12-31 | -$979.0K | n/m | 2021-02-23, From 2019-01-01 |
| 2018-12-31 | $5.85M | +7.4% | 2020-02-19, From 2018-01-01 |
| 2017-12-31 | $5.45M | n/m | 2019-02-21, From 2017-01-01 |
| 2016-12-31 | -$1.13M | n/m | 2018-03-21, From 2016-01-01 |
| 2015-12-31 | $21.64M | -24.9% | 2017-03-24, From 2015-01-01 |
| 2014-12-31 | $28.80M | +58.7% | 2016-03-21, From 2014-01-01 |
| 2013-12-31 | $18.15M | n/m | 2015-03-05, From 2013-01-01 |
| 2012-12-31 | -$2.78M | n/m | 2014-03-14, From 2012-01-01 |
| 2011-12-31 | -$20.76M | n/m | 2014-03-14, From 2011-01-01 |
| 2010-12-31 | $177.24M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $683.0K | n/a | 2012-03-12, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Viskase Holdings, Inc. (VISK) | 2025-12-31 | -$3.41M | n/m |
| Ocugen, Inc. (OCGN) | 2025-12-31 | -$67.85M | n/m |
| PharmaCyte Biotech, Inc. (PMCB) | 2026-04-30 | -$19.42M | n/m |
| Cognition Therapeutics Inc (CGTX) | 2025-12-31 | -$23.49M | n/m |
| Senti Biosciences Holdings, Inc. (SNTI) | 2025-12-31 | -$61.44M | n/m |
| Jasper Therapeutics, Inc. (JSPR) | 2025-12-31 | -$75.80M | n/m |
| Inmune Bio, Inc. (INMB) | 2025-12-31 | -$45.93M | n/m |
| IN8BIO, Inc. (INAB) | 2025-12-31 | -$19.44M | n/m |
| Sangamo Therapeutics, Inc (SGMOQ) | 2025-12-31 | -$122.93M | n/m |
Compare VISK, OCGN, PMCB, CGTX side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗